Search - tctmd.com

Displaying 201 - 220 of 284

Sort: Relevancy | Date

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Daily News

TAVR Used for Severe Regurgitation Without Stenosis

February 20, 2013

News Daily News

Radial Approach Promising in STEMI Patients with Cardiogenic Shock

L.A. McKeown

February 18, 2013

News Industry News

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

February 14, 2013

Presentation TCT 2013

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Presenter: James Lai, M. Chadi Alraies, Wael Aljaroudi, Stephen Ellis, Leslie Cho

January 31, 2013

Presentation TCT 2013

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Presenter: Nicolas DUMONTEIL, Alaide Chieffo, Didier Tchetche, Nicolas Van Mieghem, Bertrand Marcheix, Robert M A Van Der Boon, Gill Buchanan, Olivier Vahdat, Patrick Serruys, Jean Fajadet, Peter De Jaegere, Antonio Colombo, Didier Carri?

January 31, 2013

News Daily News

Citrate Preparation Prior to Angiography Reduces Contrast Nephropathy

Jason Kahn

January 31, 2013

News Daily News

Meta-Analysis Questions Strength of Link Between AKI and Mortality

Caitlin E. Cox

January 22, 2013

News Daily News

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

January 09, 2013

News Daily News

Patients Less Likely to Take Secondary Prevention Medications After CABG Than PCI

December 12, 2012

News Daily News

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Jason Kahn

December 03, 2012

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

News Conference News TCT 2012

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

October 25, 2012

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

News Conference News TCT 2012

Registries Show Low Complication Rates With New Heart Valves

October 23, 2012

Presentation TCT 2012

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Presenter: Roxana Mehran

October 23, 2012

News Industry News

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

October 22, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

Advertisement

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Remote Postconditioning Reduces AKI in NSTEMI Patients

TAVR Used for Severe Regurgitation Without Stenosis

Radial Approach Promising in STEMI Patients with Cardiogenic Shock

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Citrate Preparation Prior to Angiography Reduces Contrast Nephropathy

Meta-Analysis Questions Strength of Link Between AKI and Mortality

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

Patients Less Likely to Take Secondary Prevention Medications After CABG Than PCI

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

More Data Needed on Renal Denervation

Experts Discuss Future of Renal Denervation

Registries Show Low Complication Rates With New Heart Valves

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content